BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 927 filers reported holding BAXTER INTL INC in Q4 2016. The put-call ratio across all filers is 0.70 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $543,000 | -6.1% | 6,496 | -1.7% | 0.19% | -13.4% |
| Q3 2019 | $578,000 | +7.4% | 6,605 | +0.6% | 0.22% | +10.2% |
| Q2 2019 | $538,000 | +727.7% | 6,564 | +720.5% | 0.20% | +716.7% |
| Q1 2019 | $65,000 | +97.0% | 800 | +60.0% | 0.02% | +84.6% |
| Q4 2018 | $33,000 | -15.4% | 500 | 0.0% | 0.01% | -7.1% |
| Q3 2018 | $39,000 | +5.4% | 500 | 0.0% | 0.01% | +7.7% |
| Q2 2018 | $37,000 | -57.5% | 500 | -62.5% | 0.01% | -63.9% |
| Q1 2018 | $87,000 | +26.1% | 1,335 | 0.0% | 0.04% | +38.5% |
| Q1 2017 | $69,000 | +6.2% | 1,335 | -3.6% | 0.03% | -3.7% |
| Q3 2016 | $65,000 | -95.3% | 1,385 | +2287.9% | 0.03% | +2600.0% |
| Q1 2016 | $1,385,000 | +2030.8% | 58 | -96.5% | 0.00% | -96.7% |
| Q4 2015 | $65,000 | +103.1% | 1,635 | +66.0% | 0.03% | +25.0% |
| Q3 2015 | $32,000 | -53.6% | 985 | 0.0% | 0.02% | -51.0% |
| Q2 2015 | $69,000 | -99.9% | 985 | -39.9% | 0.05% | -36.4% |
| Q1 2015 | $112,340,000 | +95103.4% | 1,640 | +1.9% | 0.08% | -11.5% |
| Q4 2014 | $118,000 | -82.9% | 1,610 | -83.3% | 0.09% | -84.2% |
| Q3 2014 | $692,000 | -99.9% | 9,647 | -10.8% | 0.55% | -9.1% |
| Q2 2014 | $782,213,000 | – | 10,819 | – | 0.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
| Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
| NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
| PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
| Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
| Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
| Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
| Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
| Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
| Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |